The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Molecules and Cells

• Publication date

  2008-02-29

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.molcel.2007.12.018PMID 18313383
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deubiquitinating Enzyme CYLD Regulates the Peripheral Development and Naive Phenotype Maintenance of B Cells*♦

  2007cited by this paper
• Ubiquitin-mediated activation of TAK1 and IKK

  2007cited by this paper
• Reduced expression of CYLD in human colon and hepatocellular carcinomas.

  2007cited by this paper
• The tumor suppressor CYLD regulates entry into mitosis

  2007cited by this paper
• Amino-terminal Dimerization, NRDP1-Rhodanese Interaction, and Inhibited Catalytic Domain Conformation of the Ubiquitin-specific Protease 8 (USP8)*

  2006cited by this paper
• If the prophet does not come to the mountain: dynamics of signaling complexes in NF-kappaB activation.

  2006cited by this paper
• Structural Basis of Ubiquitin Recognition by the Deubiquitinating Protease USP2

  2006cited by this paper
• Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2

  2006cited by this paper
• Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO.

  2006cited by this paper
• Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation

  2006cited by this paper
• Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice.

  2006cited by this paper
• CYLD in ubiquitin signaling and tumor pathogenesis.

  2006cited by this paper
• TRPA1 is a substrate for de-ubiquitination by the tumor suppressor CYLD.

  2006cited by this paper
• Solution structure of the RBCC/TRIM B-box1 domain of human MID1: B-box with a RING.

  2006cited by this paper
• Regulation of T cell development by the deubiquitinating enzyme CYLD

  2006cited by this paper
• Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.

  2006cited by this paper
• Structure and E3‐ligase activity of the Ring–Ring complex of Polycomb proteins Bmi1 and Ring1b

  2006cited by this paper
• Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].

  2006cited by this paper
• Ubiquitin signalling in the NF-κB pathway

  2005cited by this paper
• Controlled synthesis of polyubiquitin chains.

  2005cited by this paper
• Mechanism of Lys48‐linked polyubiquitin chain recognition by the Mud1 UBA domain

  2005cited by this paper
• Chaperoned ubiquitylation--crystal structures of the CHIP U box E3 ubiquitin ligase and a CHIP-Ubc13-Uev1a complex.

  2005cited by this paper
• A genomic and functional inventory of deubiquitinating enzymes.

  2005cited by this paper
• TRIM/RBCC, a novel class of ‘single protein RING finger’ E3 ubiquitin ligases

  2005cited by this paper
• Elemental analysis of proteins by microPIXE.

  2005cited by this paper
• Structure and mechanisms of the proteasome‐associated deubiquitinating enzyme USP14

  2005cited by this paper
• Lysine 63 polyubiquitination of the nerve growth factor receptor TrkA directs internalization and signaling.

  2005cited by this paper
• Ubiquitin signalling in the NF-kappaB pathway.

  2005cited by this paper
• Coot: model-building tools for molecular graphics.

  2004cited by this paper
• Solution Structure of the Kaposi's Sarcoma-associated Herpesvirus K3 N-terminal Domain Reveals a Novel E2-binding C4HC3-type RING Domain*

  2004cited by this paper
• TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains.

  2004cited by this paper
• The novel functions of ubiquitination in signaling.

  2004cited by this paper
• HKL2MAP: a graphical user interface for macromolecular phasing with SHELX programs

  2004cited by this paper
• Identification of the protein Zibra, its genomic organization, regulation, and expression in breast cancer cells.

  2004cited by this paper
• ZZ domain of CBP: an unusual zinc finger fold in a protein interaction module.

  2004cited by this paper
• Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics

  2004cited by this paper
• Mechanism and function of deubiquitinating enzymes.

  2004cited by this paper
• The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma.

  2004cited by this paper
• ZZ domain is essentially required for the physiological binding of dystrophin and utrophin to beta-dystroglycan.

  2004cited by this paper
• De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling

  2004cited by this paper
• Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB

  2003cited by this paper
• TopDraw: a sketchpad for protein structure topology cartoons

  2003cited by this paper
• Generation, representation and flow of phase information in structure determination: recent developments in and around SHARP 2.0.

  2003cited by this paper
• The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination

  2003cited by this paper
• CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members

  2003cited by this paper
• Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde.

  2002cited by this paper
• Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit α4

  2001cited by this paper
• Identification of the familial cylindromatosis tumour-suppressor gene

  2000cited by this paper
• Ultraspiracle, a Drosophila retinoic X receptor alpha homologue, can mobilize the human thyroid hormone receptor to transactivate a human promoter.

  1997cited by this paper
• A Flexible Motif Search Technique Based on Generalized Profiles

  1996cited by this paper
• Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12–q13: evidence for its role as a tumour suppressor gene

  1995cited by this paper
• Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus

  1995cited by this paper
• Dermal eccrine cylindromatosis.

  1994cited by this paper
• ALSCRIPT: a tool to format multiple sequence alignments.

  1993cited by this paper
• Protein structure comparison by alignment of distance matrices.

  1993cited by this paper
• Electronic Reprint Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination

  year unknowncited by this paper

• Elevating Neuronal CYLD Causes Frontotemporal Dementia (FTD)-Relevant Behavioral and Physiological Deficits

  2026cites this paper
• CYLD suppresses infectious Bursal disease virus replication by deubiquitinating VP1.

  2025cites this paper
• Primary disorders of polyubiquitination: Dual roles in autoinflammation and immunodeficiency.

  2025cites this paper
• Truncating CYLD pathogenic variants in CYLD cutaneous syndrome distinctly influence CYLD proteostasis and NF-κB signaling.

  2025cites this paper
• Chimeric deubiquitinase engineering reveals structural basis for specific inhibition of the mitophagy regulator USP30

  2025cites this paper
• The good, the bad, and the modified: CYLD’s post-translational tale

  2025cites this paper
• Deubiquitinases in metabolic diseases, fibrosis and cancer of the liver.

  2025cites this paper
• Fibroblast growth factor 21 affects the colocalization of post-synaptic density 95 and Kalirin7 through CYLD-expression regulation.

  2025cites this paper
• AKT and DUBs: a bidirectional relationship

  2025cites this paper
• CYLD-TRAF6 interaction promotes ADP-heptose-induced NF-κB signaling in H. pylori infection

  2025cites this paper
• The tumor suppressor CYLD acts as a deubiquitinase for mTOR to constrain its activity

  2025cites this paper
• Linkage-specific ubiquitin binding interfaces modulate the activity of the chlamydial deubiquitinase Cdu1 towards poly-ubiquitin substrates

  2024cites this paper
• Friend or foe? Reciprocal regulation between E3 ubiquitin ligases and deubiquitinases.

  2024cites this paper
• Case report: Multiple facial trichoepitheliomas caused by p.Val835SerfsTer52 variant of CYLD gene

  2024cites this paper
• UBE2N is essential for maintenance of skin homeostasis and suppression of inflammation.

  2024cites this paper
• Chimeric deubiquitinase engineering reveals structural basis for specific inhibition of USP30 and a framework for DUB ligandability

  2024cites this paper
• CYLD induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma

  2024cites this paper
• Native Semisynthesis of Isopeptide-Linked Substrates for Specificity Analysis of Deubiquitinases and Ubl Proteases

  2023cites this paper
• The Novel Tetra-Specific Drug C-192, Conjugated Using UniStac, Alleviates Non-Alcoholic Steatohepatitis in an MCD Diet-Induced Mouse Model

  2023cites this paper
• ISGylation-independent protection of cell growth by USP18 following interferon stimulation

  2023cites this paper
• The Potential of Cylindromatosis (CYLD) as a Therapeutic Target in Oxidative Stress-Associated Pathologies: A Comprehensive Evaluation

  2023cites this paper
• YTHDC2 Retards Cell Proliferation and Triggers Apoptosis in Papillary Thyroid Cancer by Regulating CYLD-Mediated Inactivation of Akt Signaling

  2023cites this paper
• A computational approach for structural and functional analyses of disease-associated mutations in the human CYLD gene

  2023cites this paper
• SPATA2 restricts OTULIN-dependent LUBAC activity independently of CYLD.

  2023cites this paper
• The structural basis for deubiquitination by the fingerless USP-type effector TssM

  2023cites this paper
• An siRNA library screen identifies CYLD and USP34 as deubiquitinases that regulate GPCR-p38 MAPK signaling and distinct inflammatory responses

  2023cites this paper
• CYLD in health and disease

  2023cites this paper
• UBE2N is essential for maintenance of skin homeostasis and suppression of inflammation

  2023cites this paper
• Ubiquitin-specific protease 11 structure in complex with an engineered substrate mimetic reveals a molecular feature for deubiquitination selectivity

  2023cites this paper
• Exaptation of Inactivated Host Enzymes for Structural Roles in Orthopoxviruses and Novel Folds of Virus Proteins Revealed by Protein Structure Modeling

  2023cites this paper
• Methods of the enzymatic production of Ub-based tools

  2023cites this paper
• Structural Insights into the Phosphorylation-Enhanced Deubiquitinating Activity of UCHL3 and Ubiquitin Chain Cleavage Preference Analysis

  2022cites this paper
• Exaptation of inactivated host enzymes for structural roles in orthopoxviruses and novel protein folds revealed by protein structure modeling

  2022cites this paper
• Deubiquitinase cylindromatosis (CYLD) regulates antibacterial immunity and apoptosis in Chinese mitten crab (Eriocheir sinensis).

  2022cites this paper
• Novel role of macrophage TXNIP-mediated CYLD–NRF2–OASL1 axis in stress-induced liver inflammation and cell death

  2022cites this paper
• Monoubiquitination in Homeostasis and Cancer

  2022cites this paper
• Emerging Role of Ubiquitin-Specific Protease 19 in Oncogenesis and Cancer Development

  2022cites this paper
• HOIL‐1 ubiquitin ligase activity targets unbranched glucosaccharides and is required to prevent polyglucosan accumulation

  2022cites this paper
• Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes

  2022cites this paper
• CYLD variants identified in Alzheimer's disease and frontotemporal dementia patients

  2022cites this paper
• Crystal structure of a tandem B-box domain from Arabidopsis CONSTANS.

  2022cites this paper
• Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation

  2022cites this paper
• Structural insights into the catalytic mechanism and ubiquitin recognition of USP34.

  2022cites this paper
• Metastasierendes Zylindrokarzinom beim Brooke‐Spiegler‐Syndrom ‐ Fallbericht und Literaturübersicht

  2021cites this paper
• Cellular Deubiquitylating Enzyme: A Regulatory Factor of Antiviral Innate Immunity

  2021cites this paper
• Ubiquitination in the regulation of inflammatory cell death and cancer

  2021cites this paper
• Cylindromatosis Drives Synapse Pruning and Weakening by Promoting Macroautophagy through Akt-mTOR Signaling

  2021influential citation
• TRIM proteins in fibrosis.

  2021cites this paper
• Notch1 Signaling Contributed To TLR4-Triggered NF-kB Activation In Macrophages

  2021cites this paper
• Mechanism of activation and regulation of deubiquitinase activity in MINDY1 and MINDY2

  2021cites this paper
• HOIL-1-catalysed ubiquitylation of unbranched glucosaccharides and its activation by ubiquitin oligomers

  2021cites this paper
• TRAF3 and NBR1 both influence the effect of the disease‐causing CYLD(Arg936X) mutation on NF‐κB activity

  2021cites this paper
• The COP9 Signalosome Variant CSNCSN7A Stabilizes the Deubiquitylating Enzyme CYLD Impeding Hepatic Steatosis

  2021cites this paper
• Rare CYLD Variants in Chinese Patients With Amyotrophic Lateral Sclerosis

  2021cites this paper
• Regulation of CYLD activity and specificity by phosphorylation and ubiquitin-binding CAP-Gly domains

  2021cites this paper
• Spotlight on USP4: Structure, Function, and Regulation

  2021cites this paper
• MALT1 as a promising target to treat lymphoma and other diseases related to MALT1 anomalies

  2021cites this paper
• CMAR_A_268216 10639..10649

  2020cites this paper
• ubiquitin chain substrate preference to deubiquitinase (cid:24)(cid:22)(cid:19)(cid:888)(cid:891)

  2020cites this paper
• USP28 and USP25 are downregulated by Vismodegib in vitro and in colorectal cancer cell lines

  2020cites this paper
• Remodeling without Destruction: Nonproteolytic Ubiquitin Chains in Neural Function and Brain Disorders

  2020cites this paper
• Deubiquitinating Enzyme: A Potential Secondary Checkpoint of Cancer Immunity

  2020cites this paper
• Deubiquitination of NLRP6 inflammasome by Cyld critically regulates intestinal inflammation

  2020cites this paper
• A Human DUB Protein Array for Clarification of Linkage Specificity of Polyubiquitin Chain and Application to Evaluation of Its Inhibitors

  2020cites this paper
• Dissenting degradation: Deubiquitinases in cell cycle and cancer.

  2020cites this paper
• Metastatic cylindrocarcinoma in Brooke‐Spiegler Syndrome – Report of a case and review of the literature

  2020cites this paper
• CYLD is a causative gene for frontotemporal dementia - amyotrophic lateral sclerosis.

  2020cites this paper
• CYLD Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Regulating NDRG1

  2020cites this paper
• Molecular cloning and functional analysis of deubiquitinase CYLD in rainbow trout, Oncorhynchus mykiss.

  2020cites this paper
• Analysis of the Zn-Binding Domains of TRIM32, the E3 Ubiquitin Ligase Mutated in Limb Girdle Muscular Dystrophy 2H

  2019cites this paper
• Insights into ubiquitin chain architecture using Ub-clipping

  2019cites this paper
• Regulation of the Hippo signaling pathway by deubiquitinating enzymes in cancer

  2019cites this paper
• Functional analysis of deubiquitylating enzymes in tumorigenesis and development.

  2019cites this paper
• Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X

  2019cites this paper
• MicroRNA-130a has pro-fibroproliferative potential in hypertrophic scar by targeting CYLD.

  2019cites this paper
• The role of ubiquitination in the regulation of primary cilia assembly and disassembly.

  2019cites this paper
• Roles of ubiquitin in autophagy and cell death

  2019cites this paper
• Recent advances in the chemical synthesis and semi-synthesis of poly-ubiquitin-based proteins and probes

  2019cites this paper
• OTULIN protects the liver against cell death, inflammation, fibrosis, and cancer

  2019cites this paper
• The mechanism of Parkin activation by PINK1 phosphorylation

  2019cites this paper
• DEUBIQUITINATING ENZYMES PROMOTE CANCER PROGRESSION AND METASTASIS VIA REGULATING PROTEIN STABILITY

  2019cites this paper
• Differential Oligomerization of the Deubiquitinases USP25 and USP28 Regulates Their Activities.

  2019cites this paper
• Breaking the chains: deubiquitylating enzyme specificity begets function

  2019cites this paper
• USP7: Structure, substrate specificity, and inhibition.

  2019cites this paper
• Catalytic domain mutation in CYLD inactivates its enzyme function by structural perturbation and induces cell migration and proliferation.

  2018cites this paper
• Negative Regulation of Inflammation: Implications for Inflammatory Bowel Disease and Colitis Associated Cancer

  2018cites this paper
• Stabilization of the methyl-CpG binding protein ZBTB38 by the deubiquitinase USP9X limits the occurrence and toxicity of oxidative stress in human cells

  2018cites this paper
• The deubiquitinase CYLD is a specific checkpoint of the STING antiviral signaling pathway

  2018cites this paper
• Functional analysis of the C. elegans cyld-1 gene reveals extensive similarity with its human homolog

  2018cites this paper
• Modulating inflammation through the negative regulation of NF‐κB signaling

  2018cites this paper
• Frequent and differential mutations of the CYLD gene in basal cell salivary neoplasms: linkage to tumor development and progression

  2018cites this paper
• The structure of the deubiquitinase USP15 reveals a misaligned catalytic triad and an open ubiquitin-binding channel

  2018cites this paper
• TGF-β signaling pathway mediated by deubiquitinating enzymes

  2018cites this paper
• Targeting the Ubiquitin Proteasome System in Cancer

  2018cites this paper
• Targeting deubiquitinase USP28 for cancer therapy

  2018cites this paper
• Structural bases of the assembly, recognition and disassembly of linear ubiquitin chain.

  2018cites this paper
• Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma

  2018cites this paper
• Proteasome-independent functions of lysine-63 polyubiquitination in plants.

  2018cites this paper
• Characterisation of MYB and TRKB as candidate targets in CYLD cutaneous syndrome

  2018influential citation
• Receptor Tyrosine Kinase Ubiquitination and De-Ubiquitination in Signal Transduction and Receptor Trafficking

  2018cites this paper